A smartphone metabolomics platform and its application to the assessment of cisplatin-induced kidney toxicity

Analytica Chimica Acta

Volumn 845, Issue , 2014, Pages 15-22

  Kwon, Hyuknam ^a   Park, Jooeun ^a   An, Yongjin ^a   Sim, Jaeho ^b   Park, Sunghyouk ^a  

^a Seoul National University   (South Korea)

^b Chengsong MandI Co   (South Korea)

Author keywords

Drug toxicity; Metabolomics; Portable metabolomics; Smartphone

Indexed keywords

APPLICATION PROGRAMS; DATA ACQUISITION; DATA HANDLING; DATA VISUALIZATION; DECISION MAKING; LIGHT; MEDICAL APPLICATIONS; SMARTPHONES; TOXICITY;

CIS-PLATIN; EXPENSIVE EQUIPMENTS; ITS APPLICATIONS; MEDICAL DEVICES; METABOLOMICS; PROOF OF CONCEPT; TEST SAMPLES; VISIBLE LIGHT;

MHEALTH;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; INFORMATION PROCESSING; MALE; METABOLOMICS; MOBILE PHONE; NEPHROTOXICITY; NONHUMAN; PORTABLE EQUIPMENT; RAT; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS; ANIMAL; CHEMICALLY INDUCED; DEVICES; DISEASE MODEL; KIDNEY DISEASES; LIGHT; PATHOLOGY; SPRAGUE DAWLEY RAT;

CISPLATIN;

ANIMALS; CELL PHONES; CISPLATIN; DISEASE MODELS, ANIMAL; KIDNEY DISEASES; LIGHT; MALE; METABOLOMICS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84908470197     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2014.08.006     Document Type: Article

References (45)

1. O'Donnell O. Access to health care in developing countries: breaking down demand side barriers. Cad. Saude Publica 2007, 23:2820-2834.
2. Nsubuga P., Nwanyanwu O., Nkengasong J.N., Mukanga D., Trostle M. Strengthening public health surveillance and response using the health systems strengthening agenda in developing countries. BMC Public Health 2010, 10(Suppl. 1):S5.
3. Vaidya A.S., Srinivas M.B., Himabindu P., Jumaxanova D. A smart phone/tablet based mobile health care system for developing countries. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2013, 4642-4645.
4. Granot Y., Ivorra A., Rubinsky B. A new concept for medical imaging centered on cellular phone technology. PLoS One 2008, 3:e2075.
5. Tuijn C.J., Hoefman B.J., van Beijma H., Oskam L., Chevrollier N. Data and image transfer using mobile phones to strengthen microscopy-based diagnostic services in low and middle income country laboratories. PLoS One 2011, 6:e28348.
6. Tseng D., Mudanyali O., Oztoprak C., Isikman S.O., Sencan I., Yaglidere O., Ozcan A. Lensfree microscopy on a cellphone. Lab Chip 2010, 10:1787-1792.
7. Breslauer D.N., Maamari R.N., Switz N.A., Lam W.A., Fletcher D.A. Mobile phone based clinical microscopy for global health applications. PLoS One 2009, 4:e6320.
8. Zhu H., Ozcan A. Wide-field fluorescent microscopy and fluorescent imaging flow cytometry on a cell-phone. J. Vis. Exp. 2013.
9. Smith, Chu K., Espenson A.R., Rahimzadeh M., Gryshuk A., Molinaro M., Dwyre D.M., Lane S., Matthews D., Wachsmann-Hogiu S. Cell-phone-based platform for biomedical device development and education applications. PLoS One 2011, 6:e17150.
10. Oncescu V., Mancuso M., Erickson D. Cholesterol testing on a smartphone. Lab Chip 2014, 14:759-763.
11. Yetisen A.K., Martinez-Hurtado J., Garcia-Melendrez A., da Cruz Vasconcellos F., Lowe C.R. A smartphone algorithm with inter-phone repeatability for the analysis of colorimetric tests. Sens. Actuators B: Chem. 2014, 196:156-160.
12. Lee S., Oncescu V., Mancuso M., Mehta S., Erickson D. A smartphone platform for the quantification of vitamin D levels. Lab Chip 2014, 14:1437-1442.
13. Shen L., Hagen J.A., Papautsky I. Point-of-care colorimetric detection with a smartphone. Lab Chip 2012, 12:4240-4243.
14. Hong J.I., Chang B.Y. Development of the smartphone-based colorimetry for multi-analyte sensing arrays. Lab Chip 2014, 14:1725-1732.
15. Mertz L. Ultrasound? Fetal monitoring? Spectrometer? There's an app for that!: biomedical smart phone apps are taking healthcare by storm. IEEE Pulse 2012, 3:16-21.
16. Patti G.J., Yanes O., Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol. 2012, 13:263-269.
17. Monte A.A., Heard K.J., Vasiliou V. Prediction of drug response and safety in clinical practice. J. Med. Toxicol. 2012, 8:43-51.
18. Dang C.V. Links between metabolism and cancer. Genes Dev. 2012, 26:877-890.
19. Schulze A., Harris A.L. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 2012, 491:364-373.
20. Mamas M., Dunn W.B., Neyses L., Goodacre R. The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch. Toxicol. 2011, 85:5-17.
21. Andreu I., Mayorga C., Miranda M.A. Metabolomics in drug intolerance. Curr. Drug Metab. 2009, 10:947-955.
22. Kwon H.N., Kim M., Wen H., Kang S., Yang H.J., Choi M.J., Lee H.S., Choi D., Park I.S., Suh Y.J., Hong S.S., Park S. Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach. Kidney Int. 2011, 79:529-537.
23. Portilla D., Li S., Nagothu K.K., Megyesi J., Kaissling B., Schnackenberg L., Safirstein R.L., Beger R.D. Metabolomic study of cisplatin-induced nephrotoxicity. Kidney Int. 2006, 69:2194-2204.
24. Uehara T., Horinouchi A., Morikawa Y., Tonomura Y., Minami K., Ono A., Yamate J., Yamada H., Ohno Y., Urushidani T. Identification of metabolomic biomarkers for drug-induced acute kidney injury in rats. J. Appl. Toxicol. 2013.
25. Yamazaki M., Miyake M., Sato H., Masutomi N., Tsutsui N., Adam K.P., Alexander D.C., Lawton K.A., Milburn M.V., Ryals J.A., Wulff J.E., Guo L. Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats. Toxicol. Appl. Pharmacol. 2013, 268:79-89.
26. Kamp H., Fabian E., Groeters S., Herold M., Krennrich G., Looser R., Mattes W., Mellert W., Prokoudine A., Ruiz-Noppinger P., Strauss V., Walk T., Wiemer J., van Ravenzwaay B. Application of in vivo metabolomics to preclinical/toxicological studies: case study on phenytoin-induced systemic toxicity. Bioanalysis 2012, 4:2291-2301.
27. Bouhifd M., Hartung T., Hogberg H.T., Kleensang A., Zhao L. Review: toxicometabolomics. J. Appl. Toxicol. 2013, 33:1365-1383.
28. Nicholson J.K., Wilson I.D., Lindon J.C. Pharmacometabonomics as an effector for personalized medicine. Pharmacogenomics 2011, 12:103-111.
29. Clayton T.A., Lindon J.C., Cloarec O., Antti H., Charuel C., Hanton G., Provost J.P., Le Net J.L., Baker D., Walley R.J., Everett J.R., Nicholson J.K. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 2006, 440:1073-1077.
30. Brindle J.T., Antti H., Holmes E., Tranter G., Nicholson J.K., Bethell H.W., Clarke S., Schofield P.M., McKilligin E., Mosedale D.E., Grainger D.J. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med. 2002, 8:1439-1444.
31. Coen M., Lenz E.M., Nicholson J.K., Wilson I.D., Pognan F., Lindon J.C. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem. Res. Toxicol. 2003, 16:295-303.
32. D.B. Liesenfeld, N., Habermann, R.W., Owen, A., Scalbert, C.M. Ulrich, Review of mass spectrometry-based metabolomics in cancer research, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, (2013).
33. Wang X., Li K., Adams E., Van Schepdael A. Capillary electrophoresis-mass spectrometry in metabolomics: the potential for driving drug discovery and development. Curr. Drug Metab. 2013, 14:807-813.
34. Simon-Manso Y., Lowenthal M.S., Kilpatrick L.E., Sampson M.L., Telu K.H., Rudnick P.A., Mallard W.G., Bearden D.W., Schock T.B., Tchekhovskoi D.V., Blonder N., Yan X., Liang Y., Zheng Y., Wallace W.E., Neta P., Phinney K.W., Remaley A.T., Stein S.E. Metabolite profiling of a NIST standard reference material for human plasma (SRM 1950): GC-MS, LC-MS, NMR and clinical laboratory analyses, libraries and web-based resources. Anal. Chem. 2013.
35. Weckwerth W., Wienkoop S., Hoehenwarter W., Egelhofer V., Sun X. From proteomics to systems biology: MAPA, MASS, WESTERN, PROMEX, and COVAIN as a user-oriented platform. Methods Mol. Biol. 2014, 1072:15-27.
36. Menikarachchi L.C., Hill D.W., Hamdalla M.A., Mandoiu I.I., Grant D.F. In silico enzymatic synthesis of a 400,000 compound biochemical database for nontargeted metabolomics. J. Chem. Inf. Model. 2013, 53:2483-2492.
37. Kuo T.C., Tian T.F., Tseng Y.J. 3Omics: a web-based systems biology tool for analysis, integration and visualization of human transcriptomic, proteomic and metabolomic data. BMC Syst. Biol. 2013, 7:64.
38. Zhu Z.J., Schultz A.W., Wang J., Johnson C.H., Yannone S.M., Patti G.J., Siuzdak G. Liquid chromatography quadrupole time-of-flight mass spectrometry characterization of metabolites guided by the METLIN database. Nat. Protoc. 2013, 8:451-460.
39. Geladi P., Kowalski B.R. Partial least-squares regression: a tutorial. Anal. Chim. Acta 1986, 185:1-17.
40. Henney J.E. Withdrawal of troglitazone and cisapride. JAMA: J. Am. Med. Assoc. 2000, 283:2228.
41. Purhonen M., Koponen H., Tiihonen J., Tanskanen A. Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort. Pharmacoepidemiol. Drug Saf. 2012, 21:1227-1231.
42. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
43. Erickson D., O'Dell D., Jiang L., Oncescu V., Gumus A., Lee S., Mancuso M., Mehta S. Smartphone technology can be transformative to the deployment of lab-on-chip diagnostics. Lab Chip 2014.
44. Yetisen A.K., Martinez-Hurtado J., da Cruz Vasconcellos F., Simsekler M.E., Akram M.S., Lowe C.R. The regulation of mobile medical applications. Lab Chip 2014, 14:833-840.
45. Haun J.B., Castro C.M., Wang R., Peterson V.M., Marinelli B.S., Lee H., Weissleder R. Micro-NMR for rapid molecular analysis of human tumor samples. Sci. Transl. Med. 2011, 3:71ra16.